400 related articles for article (PubMed ID: 29109794)
1. Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction.
Liu Q; Zhang FG; Zhang WS; Pan A; Yang YL; Liu JF; Li P; Liu BL; Qi LW
Theranostics; 2017; 7(16):4001-4012. PubMed ID: 29109794
[No Abstract] [Full Text] [Related]
2. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
3. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
5. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
[TBL] [Abstract][Full Text] [Related]
6. Geniposide and Gentiopicroside Suppress Hepatic Gluconeogenesis via Regulation of AKT-FOXO1 Pathway.
Yang SQ; Chen YD; Li H; Hui X; Gao WY
Arch Med Res; 2018 Jul; 49(5):314-322. PubMed ID: 30409503
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg1 ameliorates palmitic acid-induced insulin resistance in HepG2 cells in association with modulating Akt and JNK activity.
Mo J; Zhou Y; Yang R; Zhang P; He B; Yang J; Li S; Shen Z; Chen P
Pharmacol Rep; 2019 Dec; 71(6):1160-1167. PubMed ID: 31675670
[TBL] [Abstract][Full Text] [Related]
9. Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice.
Nerurkar PV; Nishioka A; Eck PO; Johns LM; Volper E; Nerurkar VR
Br J Nutr; 2012 Jul; 108(2):218-228. PubMed ID: 22011624
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis
Sun X; Cao Z; Ma Y; Shao Y; Zhang J; Yuan G; Guo X
Food Funct; 2021 Feb; 12(3):1207-1218. PubMed ID: 33432947
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells.
Kim SJ; Yuan HD; Chung SH
Biol Pharm Bull; 2010; 33(2):325-8. PubMed ID: 20118562
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway.
Liu Y; Deng J; Fan D
Food Funct; 2019 May; 10(5):2538-2551. PubMed ID: 30993294
[TBL] [Abstract][Full Text] [Related]
13. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S
Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity.
Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
Int J Mol Med; 2016 Mar; 37(3):743-54. PubMed ID: 26847930
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg1 protects against d-galactose induced fatty liver disease in a mouse model via FOXO1 transcriptional factor.
Qi R; Jiang R; Xiao H; Wang Z; He S; Wang L; Wang Y
Life Sci; 2020 Aug; 254():117776. PubMed ID: 32437790
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin F
Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway.
Liu HY; Wen GB; Han J; Hong T; Zhuo D; Liu Z; Cao W
J Biol Chem; 2008 Nov; 283(45):30642-9. PubMed ID: 18786922
[TBL] [Abstract][Full Text] [Related]
18. Glucagon up-regulates hepatic mitochondrial pyruvate carrier 1 through cAMP-responsive element-binding protein; inhibition of hepatic gluconeogenesis by ginsenoside Rb1.
Lou MD; Li J; Cheng Y; Xiao N; Ma G; Li P; Liu B; Liu Q; Qi LW
Br J Pharmacol; 2019 Aug; 176(16):2962-2976. PubMed ID: 31166615
[TBL] [Abstract][Full Text] [Related]
19. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.
Tripathy S; Jump DB
J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg5 attenuates hepatic glucagon response via suppression of succinate-associated HIF-1α induction in HFD-fed mice.
Xiao N; Lou MD; Lu YT; Yang LL; Liu Q; Liu B; Qi LW; Li P
Diabetologia; 2017 Jun; 60(6):1084-1093. PubMed ID: 28280902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
